Published online Jun 7, 2015. doi: 10.3748/wjg.v21.i21.6665
Peer-review started: October 20, 2014
First decision: December 26, 2014
Revised: January 5, 2015
Accepted: February 13, 2015
Article in press: February 13, 2015
Published online: June 7, 2015
Processing time: 234 Days and 6.1 Hours
AIM: To investigate whether the proportions of acetyl-histone-positive hepatocytes could be used as markers of deteriorating liver function.
METHODS: In total, 611 cirrhotic cases from 3701 patients who were diagnosed during the past 15 years were screened, and 152 follow-up cases were selected. Paraffin tissue microarray was prepared for immunohistochemistry to examine acetyl-histone expression. The proportions of positive hepatocytes were recorded, and their correlations to clinical and laboratory indicators were analyzed statistically.
RESULTS: The proportions of H2AK5ac+, H3K9/K14ac+ and H3K27ac+ hepatocytes gradually increased with deteriorating liver function and with increasing levels of serum markers of liver injury. In the follow-up cases, patients with > 70% H2AK5ac+, H3K9/K14ac+ or H3K27ac+ hepatocytes had statistically lower survival rates (P < 0.05). Furthermore, > 70% H2AK5ac+ or H3K27ac+ hepatocytes were strong independent predictors of overall survival (P < 0.05).
CONCLUSION: The proportions of acetyl-histone-positive hepatocytes are closely associated with the liver function and prognosis of cirrhotic patients.
Core tip: We previously divided hepatocytes into transcriptionally active and inactive cells based on their immunoreactivity to acetyl-histones. In the present study, we evaluated the expression of acetyl-histone markers in livers with progressive cirrhosis to investigate whether inactive hepatocytes can be activated for functional compensation and act as markers of liver function. We found that the proportions of acetyl-histone-positive hepatocytes were associated with liver function, which revealed a regeneration-independent compensatory mechanism of chronically damaged liver. In addition, assaying the proportions of acetyl-histone-positive hepatocytes may offer a novel strategy for evaluating patient liver function and prognosis.